PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Harvard Medical School, Boston, Massachusetts, USA.\', \'Clinical Epidemiology Program, Division of Rheumatology, Allergy, and Immunology, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Division of Rheumatology, Inflammation, and Immunity, Brigham and Women\'s Hospital, Boston, Massachusetts, USA.\', \'Department of Rheumatology, Johns Hopkins Medicine, Baltimore, Maryland, USA.\', \'Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA zswallace@mgh.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/annrheumdis-2020-219279
?:doi
?:hasPublicationType
?:journal
  • Annals of the rheumatic diseases
is ?:pmid of
?:pmid
?:pmid
  • 33257496
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.699
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all